Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Function in Patients Treated for Melanoma With Adjuvant Immune Checkpoint Inhibitors: A Controlled Prospective Observational Study

NCT04565769 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT04565769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04565769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Function in Patients Treated for Melanoma With Adjuvant Immune Checkpoint Inhibitors: A Controlled Prospective Observational Study
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 12, 2020
Completion date
March 31, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cognitive impairment, cognitive impairment, depression, anxiety, fatigue, inflammation, melanoma, quality of life, sickness behavior, sleep